Anacor Pharmaceuticals, Inc. — Form D
Anacor Pharmaceuticals, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-31. The offering totals $1.6M. Industry: Pharmaceuticals.
Offering
- Filed: 2011-03-31
- Form: D
- Accession: 0001411158-11-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.6M
- Remaining: $1.6M
- Investors: 2
- Date of first sale: 2011-03-18
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-157667
Issuer
- Name: Anacor Pharmaceuticals, Inc.
- CIK: 0001411158
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1020 E. MEADOW CIRCLE, PALO ALTO, CA, 94303
- Phone: 650-543-7500
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Zhi Hong | Director | Dallas, TX |
| Richard Markham | Director | Raleigh, NC |
| Irwin Heyman | Executive Officer | Palo Alto, CA |
| Paul Berns | Director | AUSTIN, TX |
| David Perry | Director | Mount Pleasant, SC |
| David Perry | Executive Officer | Mount Pleasant, SC |
| William Rieflin | Director | South San Francisco, CA |
| Mark Leschly | Director | SANTA MONICA, CA |
| Geoffrey Parker | Executive Officer | San Francisco, CA |
| ANDERS HOVE | Director | NEW YORK, NY |
| Paul Klingenstein | Director | Lexington, MA |
| Kirk Maples | Executive Officer | Palo Alto, CA |
| Lucy Shapiro | Director | Palo Alto, CA |
| Lee Zane | Executive Officer | Palo Alto, CA |
| Sanjay Chanda | Executive Officer | MENLO PARK, CA |
| Jacob Plattner | Executive Officer | Palo Alto, CA |
Other filings by this issuer (3)
More